Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (121-130 of 362) with videos related to

Pageof 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progressionEmanuela Romano, Sylvain Pradervand, Alexandra Paillusson, et al.
Clinical Lung Cancer|September 7, 2021
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung CancerDirk De Ruysscher, Suresh Ramalingam, James Urbanic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Pulmonary sarcoid-like granulomatosis induced by ipilimumabGrégoire Berthod, Romain Lazor, Igor Letovanec, et al.
Journal for Immunotherapy of Cancer|June 14, 2020
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategyJohn Haanen, Marc Ernstoff, Yinghong Wang, et al.
Interactive Cardiovascular and Thoracic Surgery|July 19, 2021
Early discharge after thoracoscopic anatomical pulmonary resection for non-small-cell lung cancerCéline Forster, Jean Yannis Perentes, Amaya Ojanguren, et al.
Revue Medicale Suisse|November 18, 2020
[Lung cancer screening in Switzerland : Who ? How ? When ?]Alessio Casutt, Alban Lovis, Kevin Selby, et al.
HIV Medicine|November 3, 2025
Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practiceKatharine E A Darling, José Damas, Ana Leni Frei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 21, 2020
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related CholangiohepatitisLaura Moi, Hasna Bouchaab, Nuria Mederos, et al.
ERJ Open Research|March 24, 2020
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective studyChiara Pozzessere, Hasna Bouchaab, Raphael Jumeau, et al.
Revue Medicale Suisse|November 15, 2023
[Lung cancer screening : towards the implementation of a pilot project in Switzerland]Cédric Bongard, Juliana Rey Cobo, Romain Messe, et al.
Pageof 37

Showing results (121-130 of 362) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2013
Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progressionEmanuela Romano, Sylvain Pradervand, Alexandra Paillusson, et al.
Clinical Lung Cancer|September 7, 2021
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung CancerDirk De Ruysscher, Suresh Ramalingam, James Urbanic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Pulmonary sarcoid-like granulomatosis induced by ipilimumabGrégoire Berthod, Romain Lazor, Igor Letovanec, et al.
Journal for Immunotherapy of Cancer|June 14, 2020
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategyJohn Haanen, Marc Ernstoff, Yinghong Wang, et al.
Interactive Cardiovascular and Thoracic Surgery|July 19, 2021
Early discharge after thoracoscopic anatomical pulmonary resection for non-small-cell lung cancerCéline Forster, Jean Yannis Perentes, Amaya Ojanguren, et al.
Revue Medicale Suisse|November 18, 2020
[Lung cancer screening in Switzerland : Who ? How ? When ?]Alessio Casutt, Alban Lovis, Kevin Selby, et al.
HIV Medicine|November 3, 2025
Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practiceKatharine E A Darling, José Damas, Ana Leni Frei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 21, 2020
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related CholangiohepatitisLaura Moi, Hasna Bouchaab, Nuria Mederos, et al.
ERJ Open Research|March 24, 2020
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective studyChiara Pozzessere, Hasna Bouchaab, Raphael Jumeau, et al.
Revue Medicale Suisse|November 15, 2023
[Lung cancer screening : towards the implementation of a pilot project in Switzerland]Cédric Bongard, Juliana Rey Cobo, Romain Messe, et al.
Pageof 37